Fami tot posibilul cilia silabă ipf 2015 summary table 1 În orice moment Drept Ramolit
overview of major clinical trials undertaken in ipF. | Download Table
Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis | Respiratory Research | Full Text
PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of the 2011 Clinical Practice Guideline | Semantic Scholar
Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: Executive Summary
IJMS | Free Full-Text | Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5 | HTML
Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015 - Respiratory Medicine
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal
Key recommendations on pharmacological treatment of IPF according to... | Download Table
Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry - Respiratory Medicine
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study - The Lancet Respiratory Medicine
Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem,
Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients | Scientific Reports
The genetic basis of idiopathic pulmonary fibrosis | European Respiratory Society
Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis | Scientific Reports
National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research
Comparison of recommendations in the 2015 and 2011 idiopathic pulmonary... | Download Table
Table 1 from Idiopathic Pulmonary Fibrosis. | Semantic Scholar
Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment - eClinicalMedicine
Drug Interactions With Interstitial Lung Disease Pharmacotherapy
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort - The Lancet Digital Health